Home » Authors » James Etheridge

Articles by James Etheridge

Vivalis Completes EUR3M Initial Round For Transgenics Work

Feb. 12, 2003

By James Etheridge

Entomed Appoints New CEO, Advances Discovery Programs

Feb. 12, 2003

By James Etheridge

Transgene Reports Successful Results From Adenoviral Vector

Feb. 12, 2003

By James Etheridge

Vivalis Completes EUR3M Initial Round For Transgenics Work

Feb. 12, 2003

By James Etheridge

Entomed Appoints New CEO, Advances Discovery Programs

Feb. 12, 2003

By James Etheridge

Transgene Reports Successful Results From Adenoviral Vector

Feb. 12, 2003

By James Etheridge

Serono, Genentech Extend Marketing Deal For Raptiva

Feb. 12, 2003

By James Etheridge

NicOx, Biolipox Expand Alliance To Areas Of Inflammation, Pain

Feb. 5, 2003

By James Etheridge

Rebif Sales Help Push Serono Over $1.5B In 2002 Revenues

Feb. 5, 2003

By James Etheridge

Transgene Licenses Technology To Merck On Nonexclusive Basis

Feb. 5, 2003

By James Etheridge

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
GLP-1s need technologies for long-term use
BioWorld
For the long-term impact of GLP-1 therapies in obesity to be realized, they must be paired with data and digital tools. While the drugs are effective, challenges...
UTRN gene involved in arthrogryposis, study finds
BioWorld Science
Arthrogryposis multiplex congenita (AMC) is a group of disorders defined by two or more contractures in different body areas; while genes encoding sarcomeric...
HMNC raises $50M series B to prep depression drugs for phase III
BioWorld
HMNC Brain Health GmbH has raised $50 million in the first close of a series B, enabling the company to prepare the way for phase III trials of its two lead...